Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CNL Healthcare Properties (CHTH) EBITDA (2016 - 2025)

Historic EBITDA for CNL Healthcare Properties (CHTH) over the last 14 years, with Q3 2025 value amounting to $22.3 million.

  • CNL Healthcare Properties' EBITDA rose 765.15% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.5 million, marking a year-over-year increase of 1190.18%. This contributed to the annual value of $81.5 million for FY2024, which is 2784.68% up from last year.
  • CNL Healthcare Properties' EBITDA amounted to $22.3 million in Q3 2025, which was up 765.15% from $22.8 million recorded in Q2 2025.
  • In the past 5 years, CNL Healthcare Properties' EBITDA registered a high of $22.8 million during Q2 2025, and its lowest value of $3.5 million during Q4 2021.
  • For the 5-year period, CNL Healthcare Properties' EBITDA averaged around $16.9 million, with its median value being $16.7 million (2023).
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 7235.22% in 2021, then surged by 27872.4% in 2022.
  • CNL Healthcare Properties' EBITDA (Quarter) stood at $3.5 million in 2021, then surged by 278.72% to $13.3 million in 2022, then rose by 7.0% to $14.2 million in 2023, then soared by 35.62% to $19.3 million in 2024, then rose by 15.71% to $22.3 million in 2025.
  • Its last three reported values are $22.3 million in Q3 2025, $22.8 million for Q2 2025, and $21.2 million during Q1 2025.